Rentokil Market Cap from 2010 to 2024

RTO Stock  USD 25.40  0.12  0.47%   
Rentokil Initial Market Cap yearly trend continues to be very stable with very little volatility. Market Cap is likely to drop to about 1.9 B. During the period from 2010 to 2024, Rentokil Initial Market Cap quarterly data regression pattern had sample variance of 231757.1 T and median of  2,897,985,600. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
2.6 B
Current Value
1.9 B
Quarterly Volatility
481.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rentokil Initial financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rentokil Initial's main balance sheet or income statement drivers, such as Depreciation And Amortization of 498.8 M, Interest Expense of 198.4 M or Total Revenue of 5.6 B, as well as many indicators such as Price To Sales Ratio of 2.49, Dividend Yield of 0.0332 or PTB Ratio of 2.79. Rentokil financial statements analysis is a perfect complement when working with Rentokil Initial Valuation or Volatility modules.
  
Check out the analysis of Rentokil Initial Correlation against competitors.

Latest Rentokil Initial's Market Cap Growth Pattern

Below is the plot of the Market Cap of Rentokil Initial PLC over the last few years. It is Rentokil Initial's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rentokil Initial's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Rentokil Market Cap Regression Statistics

Arithmetic Mean2,560,128,377
Geometric Mean2,510,650,483
Coefficient Of Variation18.80
Mean Deviation411,836,489
Median2,897,985,600
Standard Deviation481,411,576
Sample Variance231757.1T
Range1.4B
R-Value0.45
Mean Square Error199827.7T
R-Squared0.20
Significance0.1
Slope48,063,904
Total Sum of Squares3244599.5T

Rentokil Market Cap History

20241.9 B
20232.6 B
20142.9 B
20112.1 B
20101.5 B

About Rentokil Initial Financial Statements

Rentokil Initial investors utilize fundamental indicators, such as Market Cap, to predict how Rentokil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap2.6 B1.9 B

Pair Trading with Rentokil Initial

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rentokil Initial position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rentokil Initial will appreciate offsetting losses from the drop in the long position's value.

Moving together with Rentokil Stock

  0.67G Genpact LimitedPairCorr

Moving against Rentokil Stock

  0.77MG Mistras GroupPairCorr
  0.7VLTO VeraltoPairCorr
  0.7BCO Brinks CompanyPairCorr
  0.69VCIG VCI Global LimitedPairCorr
  0.69EXPO ExponentPairCorr
The ability to find closely correlated positions to Rentokil Initial could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rentokil Initial when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rentokil Initial - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rentokil Initial PLC to buy it.
The correlation of Rentokil Initial is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rentokil Initial moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rentokil Initial PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rentokil Initial can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Rentokil Initial PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rentokil Initial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rentokil Initial Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rentokil Initial Plc Stock:
Check out the analysis of Rentokil Initial Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rentokil Initial. If investors know Rentokil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rentokil Initial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.06
Dividend Share
0.091
Earnings Share
0.99
Revenue Per Share
10.735
Quarterly Revenue Growth
0.013
The market value of Rentokil Initial PLC is measured differently than its book value, which is the value of Rentokil that is recorded on the company's balance sheet. Investors also form their own opinion of Rentokil Initial's value that differs from its market value or its book value, called intrinsic value, which is Rentokil Initial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rentokil Initial's market value can be influenced by many factors that don't directly affect Rentokil Initial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rentokil Initial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rentokil Initial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rentokil Initial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.